7.1 PAP Therapy Modalities, Mechanics & Interface Selection

7.1 PAP Therapy Modalities, Mechanics & Interface Selection

Quick Answer: Positive Airway Pressure (PAP) functions as a pneumatic splint that physically prevents pharyngeal airway collapse during sleep. CPAP delivers a single continuous pressure throughout inspiration and expiration. BiPAP/BPAP delivers two distinct pressures: EPAP (Expiratory Positive Airway Pressure) to splint the airway and eliminate obstructive apneas, and IPAP (Inspiratory Positive Airway Pressure) to augment tidal volume and eliminate hypopneas, flow limitations, and snoring. The difference is Pressure Support ($\text{PS} = \text{IPAP} - \text{EPAP}$) (standard: $4\text{--}10\text{ cm H}_2\text{O}$). Adaptive Servo-Ventilation (ASV) provides breath-by-breath variable pressure support with a backup rate for central sleep apnea and Cheyne-Stokes breathing, but is strictly contraindicated in patients with heart failure with reduced ejection fraction ($\text{LVEF} \le 45%$). Interfaces include nasal masks (first-line), nasal pillows (minimal contact, low pressure), and full-face/oronasal masks (mouth breathers, high pressure), fitted using the two-finger rule to prevent nasal bridge ulceration.

Positive airway pressure is the gold-standard non-invasive therapy for obstructive sleep apnea (OSA) and sleep-related hypoventilation disorders. A core domain tested on the BRPT CPSGT examination is the technologist's mastery of pneumatic mechanics, device modalities, interface fitting procedures, and patient safety contraindications.

---

1. Pneumatic Splint Mechanism & PAP Modalities

During normal sleep, muscle tone in the upper airway dilator muscles (notably the genioglossus, tensor veli palatini, and hyoid apparatus) decreases. In patients with anatomical narrowing or elevated tissue compliance, the negative intraluminal pressure generated during inspiration exceeds the critical closing pressure ($P_{\text{crit}}$), causing partial collapse (hypopnea) or complete collapse (obstructive apnea) in the retropalatal and retroglossal pharyngeal spaces.

PAP devices generate a positive intraluminal pressure gradient that exceeds $P_{\text{crit}}$, pushing the soft palate, tongue base, and lateral pharyngeal walls outward. This creates a continuous pneumatic splint that stabilizes the upper airway, restores functional residual capacity (FRC), normalizes alveolar ventilation, and prevents sleep-related oxyhemoglobin desaturations and EEG arousals.

+---------------------------------------------------------------------------------------------------+
|                                 PAP PNEUMATIC SPLINT MECHANISM                                    |
|                                                                                                   |
|   [Untreated OSA - Inspiration]             [PAP Therapy - Pneumatic Splint]                      |
|                                                                                                   |
|        Atmospheric Pressure (0)                  Positive Column (+4 to +20 cm H2O)               |
|                 |                                             |                                   |
|                 v                                             v                                   |
|       /-------------------\                         /-------------------\                         |
|      |    Nasal Cavity     |                       |    Nasal Cavity     |                        |
|       \-------------------/                         \-------------------/                         |
|                 |                                             |                                   |
|                 v [Negative Pressure Pull]                    v [Positive Intraluminal Outward]   |
|          --> |     | <--                              <-- |       | -->                           |
|       Pharyngeal Collapse (Pcrit)                  Patent Splinted Airway (P > Pcrit)             |
|                 x                                             |                                   |
|          [Airway Occluded]                          [Unobstructed Airflow to Lungs]               |
+---------------------------------------------------------------------------------------------------+

Primary PAP Modalities in Clinical Sleep Medicine

1. Continuous Positive Airway Pressure (CPAP)

• Operating Principle: Delivers a single, fixed pressure level throughout both the inspiratory and expiratory phases of the respiratory cycle ($4\text{ to }20\text{ cm H}_2\text{O}$ in adults).
• Physiology: CPAP splints the airway continuously. Because the patient must exhale against the incoming positive pressure column, higher CPAP settings ($>12\text{--}15\text{ cm H}_2\text{O}$) can lead to expiratory muscle fatigue, perceived difficulty exhaling, aerophagia, and sleep fragmentation.
• Primary Indications: Uncomplicated Obstructive Sleep Apnea (mild, moderate, or severe) across adult and pediatric populations.

2. Bilevel Positive Airway Pressure (BiPAP / BPAP)

• Operating Principle: Delivers two independent, synchronized positive pressure levels:
  1. Inspiratory Positive Airway Pressure (IPAP): A higher pressure delivered during patient inhalation.
  2. Expiratory Positive Airway Pressure (EPAP): A lower baseline pressure delivered during patient exhalation.
• Pressure Support Formula: $\text{Pressure Support (PS)} = \text{IPAP} - \text{EPAP}$
• Physiological Roles of IPAP vs. EPAP:
  • EPAP: Acts identically to CPAP at end-expiration. Its primary function is to prevent passive airway collapse and eliminate obstructive apneas.
  • IPAP: Overcomes inspiratory airflow resistance, expands the upper airway during active inhalation, offloads the work of breathing, and increases tidal volume ($V_T$). Its primary function is to eliminate hypopneas, respiratory effort-related arousals (RERAs), snoring, and hypercapnic hypoventilation.
  • Pressure Support (PS): Determines ventilatory augmentation. Standard AASM guidelines require a minimum PS of $4\text{ cm H}_2\text{O}$ (e.g., $8/4\text{ cm H}_2\text{O}$) and a standard maximum PS of $10\text{ cm H}_2\text{O}$ during standard titrations.
• Primary Indications:
  • CPAP pressure intolerance or expiratory discomfort at pressures $\ge 15\text{ cm H}_2\text{O}$.
  • Failure of maximum CPAP ($20\text{ cm H}_2\text{O}$) to resolve obstructive events.
  • Obesity Hypoventilation Syndrome (OHS), chronic obstructive pulmonary disease (COPD) overlap syndrome, and neuromuscular weakness.

+---------------------------------------------------------------------------------------------------+
|                                 CPAP VS. BIPAP PRESSURE WAVEFORMS                                 |
|                                                                                                   |
|   [CPAP Waveform] (Constant Single Pressure = 12 cm H2O)                                          |
|   Pressure (cm H2O)                                                                               |
|   12 |------------------------------------------------------------------------- (Constant)        |
|      |       Inspiration       |       Expiration        |       Inspiration                      |
|                                                                                                   |
|   [BiPAP Waveform] (IPAP = 14 cm H2O, EPAP = 8 cm H2O, PS = 6 cm H2O)                             |
|   Pressure (cm H2O)                                                                               |
|   14 |       /---------------\                           /---------------\     (IPAP)             |
|      |      /                 \                         /                 \                       |
|    8 |-----/                   \-----------------------/                   \--- (EPAP)            |
|      |<-- Inspiration (IPAP) ->|<-- Expiration (EPAP) ->|<-- Inspiration (IPAP)                   |
|      |<------------- Pressure Support (PS = IPAP - EPAP = 6 cm H2O) ------------>|                 |
+---------------------------------------------------------------------------------------------------+

3. Auto-Adjusting Positive Airway Pressure (APAP)

• Operating Principle: Microprocessor-controlled device that continuously tracks breath-by-breath changes in the inspiratory flow profile (flattening index), acoustic vibration (snoring), and discrete flow reductions (apneas/hypopneas), modulating output pressure between preset minimum ($P_{\text{min}}$) and maximum ($P_{\text{max}}$) thresholds.
• Indications: Treatment of uncomplicated OSA, patients with marked positional (supine vs. lateral) or sleep-stage-dependent (REM vs. NREM) pressure requirement variations, or non-attended home trials.
• Limitations in Lab: Not a substitute for attended manual in-lab titration when determining precise fixed prescription parameters for patients with significant cardiorespiratory comorbidities.

4. Adaptive Servo-Ventilation (ASV)

• Operating Principle: Advanced closed-loop bilevel servo-controller that continuously calculates a running target minute ventilation (typically $90%$ of the patient's recent baseline ventilation over a 3-minute window). It delivers a baseline EPAP to maintain upper airway patency while dynamically adjusting IPAP/PS on a breath-by-breath basis:
  • During central hypopnea or apnea, the device rapidly escalates PS and engages a timed Backup Rate (BUR) to maintain minute ventilation.
  • During hyperpnea/ventilatory overshoot, the device reduces PS to the minimum setting ($0\text{ to }3\text{ cm H}_2\text{O}$) to prevent hypocapnia and break the respiratory instability cycle.
• Primary Indications: Central Sleep Apnea (CSA), Cheyne-Stokes Breathing (CSB) without severe systolic heart failure, Treatment-Emergent Central Sleep Apnea (Complex Sleep Apnea) unresponsive to CPAP, and opioid-induced central sleep-disordered breathing.

CRITICAL EXAM WARNING — ASV Contraindication (SERVE-HF Trial): Adaptive Servo-Ventilation is ABSOLUTELY CONTRAINDICATED in patients with chronic, symptomatic heart failure (NYHA Class II–IV) with reduced ejection fraction and $\text{Left Ventricular Ejection Fraction (LVEF)} \le 45%$. The landmark SERVE-HF multicenter clinical trial demonstrated a statistically significant increase in cardiovascular mortality and all-cause mortality in this specific patient population treated with ASV. Technologists must verify cardiac history and documented ejection fraction before initiating in-lab ASV titration.

---

2. PAP Interface Types & Clinical Selection Matrix

Selecting the proper mask interface is the single most critical factor determining patient tolerance, leak management, and long-term therapeutic compliance. Interfaces are categorized by anatomical coverage and seal mechanics.

+-----------------------------------------------------------------------------------------+
|                               PAP INTERFACE SPECTRUM                                    |
|                                                                                         |
|   [Nasal Pillows]           [Nasal Mask]              [Full-Face / Oronasal]            |
|   * Minimal contact         * Standard triangle       * Covers nose & mouth             |
|   * Seals in nares          * Seals over nose         * Seals bridge to chin            |
|   * Lowest dead space       * First-line standard     * For mouth breathers             |
|   * Best for low-mod P      * Good to high P          * Best for nasal blockage         |
+-----------------------------------------------------------------------------------------+

Interface Categories Breakdown

1. Nasal Masks

• Anatomical Seal: Encloses the entire nose, seating across the bridge of the nose, nasolabial folds, and upper lip.
• Clinical Indications: First-line standard interface for most adult and pediatric patients with unobstructed nasal breathing; wide pressure tolerance range ($4\text{ to }20\text{ cm H}_2\text{O}$).
• Advantages: Excellent stability across body position changes; lower dead space volume than full-face masks; lower risk of aspiration.
• Contraindications/Limitations: Ineffective if patient has severe nasal congestion, deviated septum, or chronic mouth breathing (unless paired with an effective chinstrap).

2. Nasal Pillows

• Anatomical Seal: Soft silicone or gel prongs insert directly into the outer nares, creating a seal against the rims of the nostrils without contacting the nasal bridge.
• Clinical Indications: Patients with claustrophobia, patients with facial hair (beards/mustaches), active side or stomach sleepers, patients who read or wear eyeglasses before sleep, and patients prone to nasal bridge skin breakdown.
• Contraindications/Limitations: High pressure requirements ($>12\text{--}15\text{ cm H}_2\text{O}$) can cause uncomfortable localized airflow jetting, mucosal drying, and nares soreness; contraindicated in severe anatomical nasal obstruction.

3. Full-Face (Oronasal) Masks

• Anatomical Seal: Encloses both the nose and the mouth, extending from the bridge of the nose to the mental crease below the lower lip.
• Clinical Indications: Documented chronic mouth breathing unresponsive to chinstraps, high nasal resistance (turbinate hypertrophy, severe septal deviation, nasal polyps, acute upper respiratory infections), high therapeutic pressure requirements ($>15\text{ cm H}_2\text{O}$).
• Advantages: Prevents oral leak desynchronization by delivering equal positive pressure to both upper respiratory portals.
• Contraindications/Limitations: Highest dead space volume; increased risk of aspiration in patients with active nausea/vomiting; higher likelihood of unintentional leaks into the eyes; greater headgear strap tension required; increased risk of bridge ulceration.

4. Specialized Interfaces (Hybrid and Oral)

• Hybrid Masks: Combine nasal pillows (under the nose) with an oral cushion covering the mouth, eliminating nasal bridge contact while accommodating mouth breathers.
• Oral Masks: Seal exclusively around the oral cavity with a flanged mouthpiece; reserved for patients with complete nasal obstruction, craniofacial trauma, or nasal atresia.

---

3. Interface Sizing, Fitting Procedures & Skin Protection

Improper mask fitting is the leading cause of unintentional air leak, patient arousals, conjunctival eye irritation, and skin ulceration.

Step-by-Step Fitting Protocol

1. Static Sizing: Utilize manufacturer-specific sizing gauges/calipers while the patient is seated. Measure nasal width and height from the bridge to the upper lip (for nasal masks) or mental groove (for full-face masks). When between sizes, select the smaller size for nasal pillows (to prevent nostril dilation) and the size that does not occlude the nares or rest on the vermilion border for nasal/full-face cushions.
2. Headgear Placement: Position the headgear symmetrically around the occiput and crown. Do not overtighten.
3. Dynamic Pressure Adjustment: Connect the tubing and turn the PAP device ON to a baseline pressure ($4\text{ to }6\text{ cm H}_2\text{O}$). Positive air pressure inflates the dual-wall silicone cushion against the facial contours.
4. The "Two-Finger Rule": Adjust the headgear straps symmetrically. The technician should be able to comfortably slide two fingers beneath any headgear strap without stretching the elastic material. Overtightening crushes the silicone cushion, collapses the air-seal pocket, increases leaks, and causes facial pain.
5. Positional Verification: Have the patient assume their habitual sleeping position (lateral and supine). Test for leaks by gently turning the patient's head on the pillow.

+-----------------------------------------------------------------------------------------+
|                         CUSHION MATERIAL PROPERTIES & SELECTION                         |
|                                                                                         |
|   [Silicone Cushion]                                                                    |
|   * Properties: Lightweight, durable, dual-wall dynamic inflation with pressure.       |
|   * Maintenance: Requires daily washing to remove facial sebum/oils.                    |
|                                                                                         |
|   [Gel Cushion]                                                                         |
|   * Properties: Malleable, heavier, conforms readily to irregular facial contours.      |
|   * Clinical Use: Excellent for deep nasolabial furrows or prominent facial bones.      |
|                                                                                         |
|   [Memory Foam Cushion]                                                                 |
|   * Properties: Ultra-soft breathable seal, eliminates rigid silicone contact.          |
|   * Clinical Use: Patients with extreme skin sensitivity or early nasal bridge erythema.|
+-----------------------------------------------------------------------------------------+

Preventing Nasal Bridge Ulceration

The skin overlying the nasal bridge consists of thin epidermis stretched directly over the nasal bones with minimal subcutaneous fat. Excessive strap tension rapidly produces localized ischemia, erythema, and full-thickness ulceration.

• Preventative Strategies: Apply barrier dressings (such as thin hydrocolloid pads or silicone gel bridge guards), switch to nasal pillows or hybrid masks that bypass the nasal bridge entirely, or utilize memory foam cushions.

---

4. Comprehensive Interface Selection Matrix Table